Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2025-12-24 @ 10:35 PM
NCT ID:
NCT04140435
Eligibility Criteria:
Inclusion Criteria:
* Aged ≥ 18 years old patients.
* Patints that agree to participate in the study.
* PCLs ≥ 10mm, large enough to accommodate the microforceps.
* Patients with PCLs and high-risk features (cyst \> 3 cm, thickened wall, dilated pancreatic duct, mural nodules and solid component).
* New diagnosis of a PCL or interval changes in morphology on surveillance (cyst growth or high-risk features).
* Patients with PCLs and symptoms (e. g. pancreatitis, abdominal pain, obstructive jaundice).
* Patients with PCLs but without high-risk features and anxiety about the diagnosis.
Exclusion Criteria:
* Inability to provide informed consent for the procedure.
* Pregnancy.
* Platelet count less than 50,000/ml or International Normalized Rate (INR) \>2.
* Esophageal stricture or any pathology that does noy allows performing EUS.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04140435
Study Brief:
Protocol Section:
NCT04140435